Skin Center Medical Spa Named Among the First in Pittsburgh to Receive Newly FDA-Approved VOLUMA™ XC
VOLUMA™ XC first and only product of its kind to receive FDA-approval to correct age-related volume loss in the cheek area.
(PITTSBURGH – October 24, 2013) – The Skin Center Medical Spa will be among the first in the Pittsburgh-area to receive JUVEDERM® VOLUMA™ XC, the first and only injectable dermal filler approved in the U.S. to correct age-related volume loss in the cheek area. VOLUMA™ XC received FDA-approval on October 23, 2013, and The Skin Center Medical Spa will be one of a select group of providers nationwide to offer the treatment prior to commercial availability.
Ranked as the top medical spa in Pennsylvania and Ohio, and seventh in the nation by the Allergan Partner Privilege Program (the makers of Voluma™ and Botox® Cosmetic), The Skin Center Medical Spa & Aesthetic Practice will be given a limited amount of Voluma™ XC to treat clients prior to market-wide availability.
Voluma™ XC is the first product of its kind specifically formulated to correct age-related volume loss in the cheek area. As skin ages and loses collagen, cheeks lose volume, often leading to a flattened, sunken or sagging appearance. VOLUMA™ XC is an injectable gel filler that returns youthful volume and smoothness to the cheek area. Results are long-lasting results – up to two years in most cases.
“Voluma™ XC is an exciting innovation in the field of non-surgical cosmetic enhancement. Not only is the long-lasting formulation cost effective for our clients wanting to maintain a naturally youthful look, by delaying the need for invasive surgical options that come with a longer recovery period and time away from work,” said Dominic Brandy, MD, board-certified cosmetic surgeon and founding medical director of The Skin Center Medical Spa. “However, the benefits of a long-lasting injectable filler also comes with a word of caution — it is absolutely necessary to check the credentials of the injector and verify that they have received the appropriate training, and have an understanding of facial anatomy. Otherwise you may be disappointed with the outcome and the lasting results.”
The Skin Center Medical Spa employs expert injectors to administer Juvederm Voluma™ XC, including a National Trainer for Allergan, Inc., the makers of Botox Cosmetic and Voluma™ XC. Debra Thomas, RN, The Skin Center’s National Trainer for Allergan, Inc, travels the country teaching other medical professionals proper injection techniques for the entire family of Juvederm dermal fillers including Voluma™ as well as the most advanced applications for BOTOX® Cosmetic. As such, Thomas will be among one of the first groups trained by Allergan Inc. to inject Voluma™ XC for optimal results.
According to Allergan, Inc., Juvederm Voluma™ XC is made with proprietary VYCROSS™ technology, an advanced manufacturing process that results in a smooth gel that flows easily and consistently. This unique formulation contributes to the lift capacity to correct volume loss in the cheeks and to the duration of the product. Additionally Juvederm Voluma™ XC contains a small amount of lidocaine which helps to numb the treatment area as the product is being injected.
As reported by Allergan Inc., the most common side effects observed in the clinical trial included temporary injection-site tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration and itching. They were predominately moderate (uncomfortable) in severity, with a duration of two to four weeks.
For more than 30 years, The Skin Center Medical Spa’s team of board-certified cosmetic surgeons, board-certified plastic surgeons, vascular surgeons and nurses offer women and men advanced cosmetic plastic surgery and minimally invasive treatments for healthier-looking skin, and complete rejuvenation of the face and body.
The Skin Center Medical Spa
For Immediate Release
Contact: Nicole Conaway, 412.414.1404 (cell)
About The Skin Center Medical Spa
The Skin Center Medical Spa, with three locations in Pittsburgh, Pennsylvania and Columbus, Ohio, is the region’s premier, full-service medical spa offering the latest advancements in non-invasive and minimally invasive skin rejuvenation for the treatment of aging skin, hyper-pigmentation, rosacea, unwanted hair, varicose and spider veins, active acne and acne scarring. Established by board-certified cosmetic surgeon Dominic Brandy, MD, in 1981, The Skin Center is one of the few medical facilities in Western Pennsylvania specializing exclusively in cosmetic plastic surgery and anti-aging treatments. Dr. Brandy and his colleague Fernando Colon, MD, board-certified plastic surgeon and medical director of The Skin Center in Columbus Ohio, have a combined 50 years of experience in cosmetic plastic surgery, and together they have performed nearly 20,000 procedures. The Skin Center’s surgical facilities are accredited by the AAAHC.
The Skin Center is the only medical spa and aesthetic practice in the region to be named as one of Allergan, Inc.’s top 50 U.S. Med Spas and Aesthetic Practices in the Partner Privileges Program. Respectively making The Skin Center the number one medical spa in Pennsylvania and Ohio based on volume. As a member of the Partner Privileges Program, The Skin Center Medical Spa has the unique benefit of passing along exclusive savings, in the form of elite rebates and special product promotions, directly to our clients. Not only can our clients trust our highly-trained expert injectors and national trainer to deliver the most natural-looking results, they can also rest-assured they are getting the best value at The Skin Center as well.
About VOLUMA™ XC
The Juvederm Voluma™ formulation without lidocaine was first introduced in Europe in 2005. Juvederm Voluma™ XC with lidocaine was first introduced outside the US in 2009. As of August 31, 2013, Juvederm Voluma™ with lidocaine is distributed in 72 countries, including markets in Europe, Latin America, Middle East, Asia pacific and Canada. The Juvederm® family of products, including Juvederm Ultra and Ultra Plus, are marketed and sold in 85 countries outside the Unites States.